US Stock MarketDetailed Quotes

ASRT Assertio

Watchlist
  • 1.025
  • -0.015-1.44%
Trading May 21 14:52 ET
97.50MMarket Cap-220P/E (TTM)

About Assertio Company

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Company Profile

SymbolASRT
Company NameAssertio
Listing DateDec 2, 1997
Founded1995
CEOMs. Heather L. Mason
MarketNASDAQ
Employees53
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 South Saunders Road,Suite 300
CityLake Forest
ProvinceIllinois
CountryUnited States of America
Zip Code60045
Phone1-224-419-7106
Websitehttp://www.assertiotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Heather L. Mason
  • Director and Interim Chief Executive Officer
  • 353.02K
  • Paul Schwichtenberg
  • Senior Vice President and Chief Commercial Officer
  • 1.09M
  • Ajay Patel
  • Senior Vice President, Chief Financial Officer and Chief Accounting Officer
  • 1.06M
  • Sam Schlessinger
  • Senior Vice President and General Counsel
  • --
  • Peter D. Staple
  • Chairman of the Board
  • 377.45K
  • James L. Tyree
  • Independent Director
  • 346.89K
  • Sigurd C. Kirk
  • Independent Director
  • --
  • Sravan K. Emany
  • Independent Director
  • 223.80K
  • William T. Mckee
  • Independent Director
  • 356.52K
  • Dr. Jeffrey L. Vacirca, F.A.C.P.,M.D.
  • Independent Director
  • 245.84K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg